The first report of the working party on standardisation of lung function tests set up by the European Community for Steel The sections on static and dynamic lung volumes and carbon monoxide transfer consist of extended essays on the physiology underlying the tests with some hints on their clinical application. These are followed by detailed recommendations as to how the tests should be performed with acceptable alternatives in some instances. The summary equations have been compared with more recent data and, in general, have been retained except for There is a detailed and helpful section on the problem of calibrating pneumotachometers. For strict accuracy these devices should be calibrated separately for inspiration and expiration and for all the gas mixtures that are applicable. The compromise given is that repeated measurements of forced expiration may be made through an unheated device, provided that the instrument is not allowed to heat up gradually. Other devices such as rotating vane anemometers are noted to be used increasingly but without any comment as to their suitability or specifications. These require software to overcome the inaccuracies caused by their inertia. Like the classical devices they are governed by the general rules applying to all measuring equipment: they must be capable of external calibration and their output should be recorded or displayed graphically. The report also notes the increasing interest in methods of mneasuring displacement of the thorax and abdomen buit these are not discussed.
There is considerable detail about the measurement of lung volumes by helium dilution and by body plethysmography, with a brief mention of other methods. Closed circuit spirometry by helium dilution is recognised to be the routine method of choice for the determination of lung volumes, but it is accepted that the results will yield only an approximate figure in patients with airflow obstruction in whom plethysmographic or radio- There are recommendations for the sequence of respiratory manoeuvres to be performed in the measurement of subdivision of lung volume after the determination of functional residual capacity (FRC) or thoracic gas volume (TGV). These are quite different for the two methods. In closed circuit spirometry the determination of FRC during quiet breathing is followed by three measurements of expiratory reserve volume (ERV), the largest of which is chosen. Total lung capacity (TLC) is determined from ERV plus inspired vital capacity (IVC), measured separately after a rest. In body plethysmography the simple but inaccurate practice of measuring TGV on separate occasions and then subsequently performing a number of vital capacity manoeuvres is rightly condemned. The recommended procedure is to measure TGV and then inspire fully to TLC. TGV is to be taken as the mean of three or more determinations which differ by less than 5% from the mean; TLC is mean TGV plus the largest of the inspiratory capacities derived from a TGV which is within 5% of the mean. The residual volume (RV) is then reported as TLC minus IVC. This method has been shown to work well but it leaves the reader wondering why the reverse sequence is superior during closed circuit spirometry. The explanation lies in the fact that patients with airflow obstruction can reproducibly reach both TLC by a forceful inspiratory effort and RV by a gentle but prolonged exhalation. The measurement of RV starting at TLC has to be avoided because airway closure occurs at a higher volume. The advice regarding closed circuit spirometry is similar to that given in 1983, with the exception that a rather inaccurate correction for the supposed uptake of helium in body fluids during rebreathing has been removed.
Throughout the report there is emphasis on the IVC which is usually the largest value in airflow obstruction. Measurement of peak expiratory flow is hardly mentioned as it is to be the subject of another document, but it is worth noting that an increase in peak flow of 60 1/min is regarded as a criterion for reversibility of airflow obstruction.
Transfer factor for carbon monoxide The working party has again opted for the name "transfer factor" rather than "diffusing capacity" for this test. The reasons are those originally given: that the procedure does not measure diffusion but whole lung carbon monoxide (CO) uptake, and the result is not strictly a "capacity" because it is capable of increasing-for example, in exercise or recumbency.
The working party recommends that transfer factor should be reported as the CO transfer coefficient in STPD units multiplied by the alveolar volume (VA) in BTPS units. This has important consequences for the reporting of transfer coefficient (TLco/VA) because, in most studies, this is derived by calculating whole lung TLco and dividing it by the alveolar volume either in BTPS or STPD units. Since there is a 20% difference between these, lack of standardisation has led to important misunderstandings. This was evident in the summary equations for transfer coefficient published in the 1983 document which have now been withdrawn. Surprisingly, the original papers employed to derive the summary equations calculated TLCO/VA in a number of different ways." TLCONA is best regarded as a number which gives useful clinical information in several well defined situations such as the identification of pulmonary emphysema and the diagnosis of a chest wall or pleural component of a restrictive ventilatory defect. It is probably best to calculate the "expected" value of TLCo/VA from the expected values of its two components.
The report tackles the vexed question of the correct VA to employ in the calculation of single breath TLco. It is recommended that the measurement should be made without undue pressure or suction at a lung volume corresponding to at least 90% of IVC. Transfer coefficient is to be multiplied by the TLC derived from another measurement such as closed circuit helium spirometry. This is the original recommended method and has the merit of ensuring that lung volumes are measured when transfer factor is to be reported, as some clinical information is lost if they are not. Nevertheless it is difficult to accept the reasoning that, because the single breath VA underestimates TLC in patients with chronic airflow obstruction, this somehow underestimates the Tico. The advantage of calculating VA during the single breath is that TLco can be defined in physiological terms as the carbon monoxide uptake in the ventilated portion of the lung at TLC (assuming that this is a single "effective" compartment). Since we do not know whether the inaccessible or unventilated portion of the lung is perfused or not, it seems pointless to include it in the whole lung transfer factor by assuming that it has the same vascularity as the accessible portion in which uptake is measured.
It is recognised that, for epidemiological studies, the single breath VA may be preferable. Although single breath RV is the same as multiple breath RV in normal subjects, corrections to TLC yield a consistent error in the calculation of TLCO if the breath is held at a volume lower than this. The American Thoracic Society recommends the use of the single breath VA for clinical and epidemiological purposes; most laboratories adhere to this.
The use of 17-18% oxygen in the inspired gas mixture is recommended. This yields the least variability in alveolar oxygen pressure (and also has the merit of being the cheapest option as helium and carbon monoxide can simply be added to air). The formula of Kanner The document hints that measurement of the pulmonary blood volume may be useful clinically, which is surprising. It is pointed out that the value of theta is only an estimate.
Bronchial challenge
Bronchial challenge remains a research procedure in the UK and has a limited clinical role worldwide. This section therefore has a somewhat different status from the remainder of the standardisation document. It is a very well written and sensibly argued account of the application and usefulness of different types of bronchoconstrictor challenge. What may loosely be called bronchial hyperreactivity is quite common in healthy subjects (around 10%) and is a feature of chronic airflow obstruction. Bronchial challenge testing cannot therefore be used to diagnose asthma unless a definition is used which is so stringent that it becomes very insensitive. A normal bronchial challenge has negative predictive value-that is, it excludes asthma with a high degree of probability.
Since these procedures are likely to become more widespread in the UK as elsewhere, the recommendations of the working party are useful. For safety it is suggested that the operator should always be experienced in the emergency treatment of asthma, that there should be a physician on call able to reach the scene within 10 minutes, and that for antigen challenges a physician should invariably be present. Measurement of FEVy is recommended except for research in normal subjects when sensitive but less repeatable indices such as specific airway conductance may be useful. In bronchial challenge work repeatability within subjects is of paramount importance. There are detailed accounts of how different challenges may be performed in a reproducible manner. This document refreshingly combines enthusiasm, scepticism, and sound practice; it deserves reading for its own sake, regardless of any advice about standardisation that it may contain.
Benefits of standardisation
There are a number of reasons why published standards can be helpful. These guidelines run them altogether without comment: thus, it has to be read as a whole. The main objectives are to improve reproducibility within subjects and to ensure that, if a subject visits two different laboratories on the same day, similar results will be produced. There are recommendations regarding the sequence in which tests are to performed, the minimum specification required for the equipment, and safety measures. There are suggested performance standards for equipment, and manufacturers should be able to state how far their products conform to them. Facilities for external calibration must always be provided in spite of increasing automation and computerisation. Editors and reviewers of scientific articles will enquire whether standard methods have been used and this document will provide them with a strong basis for questioning slipshod techniques.
The members of the working party have taken a generous view of the imperfections of biological measurement and of the resistance of individuals to change for its own sake. Editors will similarly show sympathy towards researchers with limited resources working under difficult conditions whose measurements may not conform strictly to European or American standards. Nevertheless, there is no point in publishing numerical results if their validity cannot be assessed. By avoiding dogma and, in the main, perfectionism, the working party has made a major contribution to the practice of physiological measurement in respiratory medicine.
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